Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $0.13 USD
Change Today +0.001 / 0.77%
Volume 1.5K
As of 5:19 PM 08/4/15 All times are local (Market data is delayed by at least 15 minutes).

american bio medica corp (ABMC) Snapshot

Previous Close
Day High
Day Low
52 Week High
11/5/14 - $0.90
52 Week Low
12/22/14 - $0.10
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield

Related News

No related news articles were found.

american bio medica corp (ABMC) Related Businessweek News

No Related Businessweek News Found

american bio medica corp (ABMC) Details

American Bio Medica Corporation develops, manufactures, and sells immunoassay tests for the immediate point of collection testing (POCT) for drugs of abuse (DOA) in urine and oral fluids. The company provides urine-based POCT products that comprise Rapid Drug Screen to detect the presence or absence of 2 to 10 DOA; Rapid ONE for testing the presence or absence of a single DOA; RDS InCup, which detects the presence or absence of 2 to 12 DOA; Rapid TOX that detects the presence or absence of 2 to 10 DOA; and Rapid TOX Cup II for detecting the presence or absence of 2 to 14 DOA. Its urine-based POCT products test various drugs, including amphetamines, barbiturates, benzodiazepines, buprenorphine, cocaine, MDMA, methadone, methamphetamines, opiates, oxycodone, phencyclidine (PCP), propoxyphene, marijuana (THC), and tricyclic antidepressants. The company also offers oral fluid based POCT products comprising OralStat that test amphetamines, barbiturates, benzodiazepines, cocaine, MDMA, methadone, methamphetamines, opiates, PCP, propoxyphene, and THC drugs to detect DOA. In addition, it distributes Rapid Reader, a compact portable unit, which uses a camera to capture a picture of the results obtained when using an ABMC POCT product; and POCT products to detect the presence or absence of adulterants and alcohol. Further, the company offers bulk strip contract manufacturing services to various non-affiliated POCT diagnostic companies. American Bio Medica Corporation serves workplace, government, clinical/pain management, rehabilitation/drug treatment, and education markets directly, as well as through distributors in the United States and internationally. The company was formerly known as American Micro Media, Inc. and changed its name to American Bio Medica Corporation in September 1992. American Bio Medica Corporation was founded in 1986 and is based in Kinderhook, New York.

67 Employees
Last Reported Date: 03/31/15
Founded in 1986

american bio medica corp (ABMC) Top Compensated Officers

Chief Executive Officer, Principal Accounting...
Total Annual Compensation: $137.5K
Compensation as of Fiscal Year 2014.

american bio medica corp (ABMC) Key Developments

American Bio Medica Corporation Enters Three-Year Loan and Security Agreement with Crestmark Bank

American Bio Medica Corporation entered into a three-year loan and security agreement with Crestmark Bank, a new Senior Lender, to refinance the company's line of credit with Michaelson Capital Special Finance Fund, LP. The Crestmark Line of Credit is to be used for working capital and general corporate purposes. Under theloan and security agreement, Crestmark has agreed to provide the company with a Line of Credit of up to $1,500,000 with a minimum loan balance requirement of $500,000. The Line of Credit is secured by a first security interest in the company's inventory, and receivables and security interest in all other assets of the company.

American Bio Medica Corp. Announces Unaudited Earnings Results for the First Quarter Ended March 31, 2015

American Bio Medica Corp. announced unaudited earnings results for the first quarter ended March 31, 2015. For the quarter, the company's net sales were $1.5 million compared with $2.0 million a year ago. The decline in sales in the first quarter 2015 was primarily due to the loss of two state contracts in 2014 (both of which are now using a product manufactured outside of the United States). Operating loss was $0.05 million compared with operating income of $0.06 million a year ago. Net loss before tax was $0.05 million compared with income of $0.01 million a year ago. Net loss was $0.05 million compared with net income of $0.009 million a year ago.

American Bio Medica Corp., Annual General Meeting, Jun 18, 2015

American Bio Medica Corp., Annual General Meeting, Jun 18, 2015., at 10:00 US Eastern Standard Time. Location: The Company's Corporate Offices. Agenda: To elect two Class II directors for three year terms commencing upon their election and until their successor shall be elected and duly qualified; to ratify the selection by the Company's Audit Committee of Liggett, Vogt & Webb, P.A. as the Company's independent registered public accounting firm for the year ending December 31, 2015; and to transact any other business as may properly come before the Annual Meeting.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ABMC:US $0.13 USD +0.001

ABMC Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Alere Inc $52.68 USD +2.59
OraSure Technologies Inc $5.00 USD +0.04
View Industry Companies

Industry Analysis


Industry Average

Valuation ABMC Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 0.5x
Price/Book 2.8x
Price/Cash Flow NM Not Meaningful
TEV/Sales 0.1x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact AMERICAN BIO MEDICA CORP, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at